Clinical Trial Update: Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tight control dose reductions of biologics in psoriasis patients with low disease activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Snippet

Sponsor: Radboud University Medical Center | Conditions: Psoriasis | Phase 4 | Status: COMPLETED